MEDICAL CITIES, INC. – Trademark Portfolio
Entity Type: 03
MEDICAL CITIES, INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MEDICAL CITY and MEDICAL CITY DALLAS. The owner is based in DALLAS, TX.
7777 FOREST LANE
BUILDING C, SUITE 840
DALLAS, TX 75230
Showing of trademarks Trademarks
Trademark Classifications
MEDICAL CITIES, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does MEDICAL CITIES, INC. have?
MEDICAL CITIES, INC. has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 2 cancelled.
What trademark classes does MEDICAL CITIES, INC. file in?
MEDICAL CITIES, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are MEDICAL CITIES, INC.'s most well-known trademarks?
MEDICAL CITIES, INC.'s registered trademark portfolio includes well-known marks such as MEDICAL CITY and MEDICAL CITY DALLAS. These are among 2 currently registered trademarks in the portfolio.
What is MEDICAL CITIES, INC.'s trademark registration success rate?
MEDICAL CITIES, INC. has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.